🕵️ Nurix Therapeutics, Inc. ($NRIX)
SEC insider & ownership activity, last 12 months · CIK 1549595 · every row links its SEC filing
Over the last 12 months insiders sold $4.5M with no open-market buying against it. Ring Christine sold $3.3M through a 10b5-1 trading plan in 20 lots (Oct–Sep). 1 planned sale is pending, the largest $95K (Gwenn M. Hansen). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $4.5M (40 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ring Christine | 0 | – | 20 | $3.3M | Sep 2, 2026 |
| Johannes Van Houte | 0 | – | 10 | $635K | Aug 4, 2026 |
| Gwenn M. Hansen | 0 | – | 10 | $631K | Sep 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.2% | 13G | Apr 23, 2025 | filing ↗ | |
| Redmile Group, LLC | 8.1% | 13G | Aug 14, 2026 | filing ↗ | |
| Jeremy C. Green | 8.1% | 13G | Aug 14, 2026 | filing ↗ | |
| Vestal Point Capital, LP | 7.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Ryan Wilder | 7.8% | 13G | Aug 14, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 7.5% | 13G | Aug 14, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 7.5% | 13G | Aug 14, 2026 | filing ↗ | |
| David Kroin | 7.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Baker BROS. Advisors LP | 7.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 7.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Julian C. Baker | 7.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Felix J. Baker | 7.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Rubric Capital Management LP | 7.0% | 13G | Aug 14, 2026 | filing ↗ | |
| David Rosen | 7.0% | 13G | Aug 14, 2026 | filing ↗ | |
| FMR LLC | 5.4% | 13G | May 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 5.4% | 13G | May 6, 2026 | filing ↗ | |
| T. ROWE Price Associates, Inc. | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Commodore Capital LP | 5.1% | 13G | Feb 14, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.0% | 13G | Jul 31, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Christine Ring | $151K | Sep 2, 2026 | filing ↗ |
| Gwenn Hansen | $215K | Aug 5, 2026 | filing ↗ |
| Gwenn M. Hansen | $95K | Aug 4, 2026 | filing ↗ |
| Johannes Van Houte | $111K | Aug 4, 2026 | filing ↗ |
| Christine Ring | $385K | Aug 3, 2026 | filing ↗ |
| Christine Ring | $263K | Jul 2, 2026 | filing ↗ |
| Christine Ring | $558K | Jun 25, 2026 | filing ↗ |
| Gwenn M. Hansen | $104K | Jun 25, 2026 | filing ↗ |
| Christine Ring | $142K | Jun 2, 2026 | filing ↗ |
| Johannes Van Houte | $238K | May 5, 2026 | filing ↗ |
| Christine Ring | $137K | May 4, 2026 | filing ↗ |
| Christine Ring | $90K | May 1, 2026 | filing ↗ |
| Christine Ring | $126K | Apr 2, 2026 | filing ↗ |
| Christine Ring | $130K | Mar 2, 2026 | filing ↗ |
| Christine Ring | $240K | Feb 9, 2026 | filing ↗ |
| Christine Ring | $137K | Dec 18, 2025 | filing ↗ |
| Christine Ring | $630K | Nov 24, 2025 | filing ↗ |
| Johannes Van Houte | $81K | Nov 3, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | Apr 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 8, 2026 | filing ↗ |
| Other events (8.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Earnings (2.02) | Jan 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 6, 2025 | filing ↗ |
| Other events (8.01) | Dec 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 22, 2025 | filing ↗ |
| Other events (8.01) | Oct 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 22, 2025 | filing ↗ |
| Other events (8.01) | Oct 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 22, 2025 | filing ↗ |
| Earnings (2.02) | Oct 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 9, 2025 | filing ↗ |